Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial.

  • Abed H
  • Wittert G
  • Leong D
 et al. 
  • 28

    Readers

    Mendeley users who have this article in their library.
  • N/A

    Citations

    Citations of this article.

Abstract

IMPORTANCE: Obesity is a risk factor for atrial fibrillation. Whether weight reduction and cardiometabolic risk factor management can reduce the burden of atrial fibrillation is not known.

OBJECTIVE: To determine the effect of weight reduction and management of cardiometabolic risk factors on atrial fibrillation burden and cardiac structure.

DESIGN, SETTING, AND PATIENTS: Single-center, partially blinded, randomized controlled study conducted between June 2010 and December 2011 in Adelaide, Australia, among overweight and obese ambulatory patients (N = 150) with symptomatic atrial fibrillation. Patients underwent a median of 15 months of follow-up.

INTERVENTIONS: Patients were randomized to weight management (intervention) or general lifestyle advice (control). Both groups underwent intensive management of cardiometabolic risk factors.

MAIN OUTCOMES AND MEASURES: The primary outcomes were Atrial Fibrillation Severity Scale scores: symptom burden and symptom severity. Scores were measured every 3 months from baseline to 15 months. Secondary outcomes performed at baseline and 12 months were total atrial fibrillation episodes and cumulative duration measured by 7-day Holter, echocardiographic left atrial area, and interventricular septal thickness.

RESULTS: Of 248 patients screened, 150 were randomized (75 per group) and underwent follow-up. The intervention group showed a significantly greater reduction, compared with the control group, in weight (14.3 and 3.6 kg, respectively; P 
CONCLUSIONS AND RELEVANCE: In this study, weight reduction with intensive risk factor management resulted in a reduction in atrial fibrillation symptom burden and severity and in beneficial cardiac remodeling. These findings support therapy directed at weight and risk factors in the management of atrial fibrillation.

TRIAL REGISTRATION: anzctr.org.au Identifier: ACTRN12610000497000.

Author-supplied keywords

  • Aged
  • Atrial Fibrillation
  • Atrial Fibrillation: complications
  • Atrial Fibrillation: diet therapy
  • Diet, Reducing
  • Echocardiography
  • Fish Oils
  • Fish Oils: administration & dosage
  • Heart Atria
  • Heart Atria: pathology
  • Heart Atria: ultrasonography
  • Humans
  • Life Style
  • Male
  • Middle Aged
  • Obesity
  • Obesity: complications
  • Obesity: diet therapy
  • Overweight
  • Overweight: complications
  • Overweight: diet therapy
  • Risk Factors
  • Severity of Illness Index
  • Treatment Outcome
  • Weight Loss

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Authors

  • Hany S Abed

  • Gary a Wittert

  • Darryl P Leong

  • Masoumeh G Shirazi

  • Bobak Bahrami

  • Melissa E Middeldorp

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free